H Mauch Selected Research

H Mauch Research Topics

8	Tuberculosis (Tuberculoses) 04/2012 - 01/2001
4	Respiratory Tract Infections (Respiratory Tract Infection) 08/2007 - 01/2000
3	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 07/2014 - 04/2001
3	Healthcare-Associated Pneumonia 06/2006 - 01/2000
2	Latent Tuberculosis 04/2012 - 01/2006
2	Infections 02/2004 - 01/2000
1	Lymphadenitis (Adenitis) 08/2007
1	Hypoxia (Hypoxemia) 07/2006
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 06/2006
1	Chronic Pancreatitis 06/2006
1	Sepsis (Septicemia) 06/2006
1	Acute Kidney Injury (Acute Renal Failure) 06/2006
1	Pulmonary Tuberculosis 06/2006
1	Brain Neoplasms (Brain Tumor) 07/2005
1	Lung Abscess 02/2004
1	Aspiration Pneumonia 02/2004
1	Pneumonia (Pneumonitis) 06/2003
1	Lung Diseases (Lung Disease) 06/2003
1	Chronic Bronchitis 06/2003
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 03/2002
1	Sinusitis 04/2000

3	Interferon-gamma (Interferon, gamma)IBA 04/2012 - 01/2006
2	Tuberculin (PPD)IBA 01/2006 - 10/2005
2	Cephalosporins (Cephalosporin Antibiotics)IBA 02/2004 - 01/2000
2	Pharmaceutical PreparationsIBA 04/2001 - 01/2001
2	Anti-Bacterial Agents (Antibiotics)IBA 04/2000 - 01/2000
1	Aminosalicylic Acid (Rezipas)FDA Link 04/2012
1	GoldIBA 08/2007
1	AntibodiesIBA 10/2005
1	sultamicillin (ampicillin-sulbactam)FDA LinkGeneric 02/2004
1	Clindamycin (Cleocin)FDA LinkGeneric 02/2004
1	ProcalcitoninIBA 06/2003
1	SteroidsIBA 03/2002
1	Itraconazole (Sporanox)FDA LinkGeneric 03/2002
1	Voriconazole (Vfend)FDA LinkGeneric 03/2002
1	sparfloxacin (AT 4140)FDA Link 04/2001
1	AgarIBA 01/2001
1	Moxifloxacin (Avelox)FDA Link 04/2000

4	Therapeutics 07/2014 - 01/2000
1	Noninvasive Ventilation 07/2006
1	Critical Care (Surgical Intensive Care) 06/2006
1	Artificial Respiration (Mechanical Ventilation) 06/2006
1	Radiotherapy 07/2005
1	Contraindications 03/2002